NEW MJ NEWS

Aphria, Inc. to Host Earnings Call

Aphria, Inc. (NASDAQ:APHA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on October 15, 2020 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/68446

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

– ADVERTISEMENT –

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

View source version on accesswire.com:
https://www.accesswire.com/610575/Aphria-Inc-to-Host-Earnings-Call


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tilray Brands, Inc. (TLRY) Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada

Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across…

$ENRT Announces Lithium Carbonate

Enertopia Announces Lithium Carbonate Enertopia Corporation (OTCQB: ENRT; CSE: TOP) (the “Company”…

Sundial Growers (SNDL) to Announce Full Year and Fourth Quarter 2020 Financial Results on March 17, 2021

Sundial Growers to Announce Full Year and Fourth Quarter 2020 Financial Results…

Tetra Bio-Pharma Inc. (TBPMF) Announces Closing of Bought Deal Financing

Tetra Bio-Pharma Announces Closing of Bought Deal Financing Tetra Bio-Pharma Inc. (“Tetra”…